2023

Toronto, Ontario – March 31, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“)

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical announces the return of Veronique Laberge as Chief Financial Officer and Corporate Secretary Toronto, Ontario – March 10th,

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director.